HK1245831A1 - 用於生產TCRγδ+ T細胞的方法 - Google Patents
用於生產TCRγδ+ T細胞的方法Info
- Publication number
- HK1245831A1 HK1245831A1 HK18105236.3A HK18105236A HK1245831A1 HK 1245831 A1 HK1245831 A1 HK 1245831A1 HK 18105236 A HK18105236 A HK 18105236A HK 1245831 A1 HK1245831 A1 HK 1245831A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cells
- production
- methods
- gamma delta
- tcr gamma
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 title 1
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4631—Chimeric Antigen Receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2315—Interleukin-15 (IL-15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2321—Interleukin-21 (IL-21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT2015047568 | 2015-06-09 | ||
PT2016032002 | 2016-05-12 | ||
PCT/EP2016/063077 WO2016198480A1 (en) | 2015-06-09 | 2016-06-08 | Methods for the production of tcr gamma delta+ t cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1245831A1 true HK1245831A1 (zh) | 2018-08-31 |
Family
ID=56132913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18105236.3A HK1245831A1 (zh) | 2015-06-09 | 2018-04-23 | 用於生產TCRγδ+ T細胞的方法 |
Country Status (10)
Country | Link |
---|---|
US (3) | US11166983B2 (zh) |
EP (2) | EP3307875B1 (zh) |
JP (1) | JP6799895B2 (zh) |
CN (2) | CN108350428B (zh) |
AU (2) | AU2016274633B2 (zh) |
CA (1) | CA2988050A1 (zh) |
EA (1) | EA201890013A1 (zh) |
HK (1) | HK1245831A1 (zh) |
WO (1) | WO2016198480A1 (zh) |
ZA (1) | ZA201800121B (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015350103A1 (en) * | 2014-11-17 | 2017-06-29 | Adicet Bio, Inc. | Engineered gamma delta T-cells |
MY198084A (en) | 2015-10-30 | 2023-07-31 | Cancer Research Tech Ltd | Expansion of non-haematopoietic tissue-resident ()()t cells and uses of these cells |
KR102519861B1 (ko) * | 2016-05-12 | 2023-04-10 | 아디셋 바이오, 인크. | γδ T-세포 집단의 선택적 확장을 위한 방법 및 그의 조성물 |
WO2018052947A1 (en) * | 2016-09-16 | 2018-03-22 | Baylor College Of Medicine | Platform for activation and expansion of virus-specific t-cells |
GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
WO2018229163A1 (en) * | 2017-06-14 | 2018-12-20 | King's College London | Methods of activating v delta 2 negative gamma delta t cells |
SG11202004506WA (en) * | 2017-11-15 | 2020-06-29 | Adicet Bio Inc | METHODS FOR SELECTIVE EXPANSION OF d3 ?d T-CELL POPULATIONS AND COMPOSITIONS THEREOF |
EP3743081A4 (en) * | 2018-01-23 | 2021-12-01 | New York University | SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR |
GB201804701D0 (en) | 2018-03-23 | 2018-05-09 | Gammadelta Therapeutics Ltd | Lymphocytes expressing heterologous targeting constructs |
MX2021003745A (es) | 2018-10-01 | 2021-05-14 | Adicet Bio Inc | Composiciones y métodos relacionados con células t gamma delta modificadas y no modificadas para el tratamiento de tumores hematológicos. |
CA3115059A1 (en) | 2018-10-01 | 2020-04-09 | Adicet Bio Inc. | Compositions and methods regarding engineered and non-engineered .gamma..delta.-t cells for treatment of solid tumors |
WO2020172555A1 (en) * | 2019-02-21 | 2020-08-27 | Regents Of The University Of Minnesota | Genetically modified gamma delta t cells and methods of making and using |
MX2021015448A (es) * | 2019-06-14 | 2022-06-08 | G Tech Bio Llc | Células linfocíticas activadas y métodos para usarlas para tratar cáncer y afecciones infecciosas. |
CA3145523A1 (en) | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Therapeutic uses of anti-tcr delta variable 1 antibodies |
US20220290101A1 (en) | 2019-08-16 | 2022-09-15 | GammaDelta Therapeutics Limited | Ex vivo gamma delta t cell populations |
US20220387489A1 (en) * | 2019-10-17 | 2022-12-08 | The University Of Hong Kong | Methods to prepare v-t cells derived exosomes for treatment of epstein-barr virus-associated cancers |
CN115151565A (zh) | 2019-10-31 | 2022-10-04 | 莫佛塞斯公司 | 包含抗CD19抗体和γδT细胞的抗肿瘤组合疗法 |
KR20230013022A (ko) | 2020-03-20 | 2023-01-26 | 감마델타 테라퓨틱스 엘티디 | 골수성 악성종양의 치료를 위한 v 델타1+ t 세포 |
JP2023537161A (ja) * | 2020-08-14 | 2023-08-30 | シャンハイ・シンフア・バイオ・ファーマスーティカル・サイエンス・アンド・テクノロジー・カンパニー・リミテッド | ユニバーサル免疫細胞の製造方法及びその応用 |
CN116209456A (zh) | 2020-08-14 | 2023-06-02 | 伽马三角洲疗法有限公司 | 多特异性抗TCRδ可变1抗体 |
CA3202233A1 (en) * | 2020-11-18 | 2022-05-27 | Kiromic BioPharma, Inc. | Gamma-delta t cell manufacturing processes and chimeric pd1 receptor molecules |
WO2022175414A1 (en) | 2021-02-17 | 2022-08-25 | Adaptate Biotherapeutics Ltd. | Multispecific anti-tcr delta variable 1 antibodies |
AU2022322052A1 (en) | 2021-08-03 | 2024-02-29 | Gammadelta Therapeutics Ltd | Engineering of gamma delta t cells and compositions thereof |
TW202341971A (zh) | 2022-02-16 | 2023-11-01 | 法商普萊歐塞拉公司 | 使用car細胞及s1p受體調節劑之治療方法 |
GB202204926D0 (en) | 2022-04-04 | 2022-05-18 | Gammadelta Therapeutics Ltd | Method for expanding gammadelta T cells |
WO2023194915A1 (en) | 2022-04-04 | 2023-10-12 | Gammadelta Therapeutics Ltd | Novel gene armoring |
US11750950B1 (en) * | 2022-05-26 | 2023-09-05 | Omnivision Technologies, Inc. | Voltage domain global shutter readout circuit timing |
CN115678846B (zh) * | 2022-09-01 | 2023-06-16 | 广东龄值生物科技有限公司 | 一种肿瘤特异性γδT细胞及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2349629C (en) | 1998-11-04 | 2010-01-26 | Hemosol Inc. | Methods for the production of tcr gamma delta t cells |
AU2001248162B2 (en) * | 2000-04-03 | 2007-02-01 | Hemosol Lp. | Production of TcR gamma delta T cells |
US20030157060A1 (en) | 2000-04-03 | 2003-08-21 | Bell David N | Production of tcr gamma delta t cells |
US9018004B2 (en) * | 2005-11-18 | 2015-04-28 | University Health Network | Method of expanding double negative T cells |
US20110158954A1 (en) * | 2007-03-09 | 2011-06-30 | Mitsuko Ideno | Method for producing gamma delta t cell population |
EP2629605B1 (en) | 2010-10-21 | 2016-12-28 | Syngenta Limited | Agrochemical concentrates comprising alkoxylated adjuvants |
ES2643387T3 (es) * | 2011-05-19 | 2017-11-22 | Instituto De Medicina Molecular | Estirpe celular de linfocitos que comprende células gama-delta, composición y método de producción de la misma |
EP3060059A4 (en) | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
AU2015350103A1 (en) * | 2014-11-17 | 2017-06-29 | Adicet Bio, Inc. | Engineered gamma delta T-cells |
AU2017298142B2 (en) | 2016-07-18 | 2021-11-11 | Arthrosi Therapeutics, Inc. | Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia |
CN106399245A (zh) * | 2016-11-30 | 2017-02-15 | 广州赛莱拉干细胞科技股份有限公司 | 一种γδT细胞的培养方法 |
-
2016
- 2016-06-08 EP EP16729531.0A patent/EP3307875B1/en active Active
- 2016-06-08 AU AU2016274633A patent/AU2016274633B2/en active Active
- 2016-06-08 CN CN201680047265.4A patent/CN108350428B/zh active Active
- 2016-06-08 CA CA2988050A patent/CA2988050A1/en active Pending
- 2016-06-08 WO PCT/EP2016/063077 patent/WO2016198480A1/en active Application Filing
- 2016-06-08 EA EA201890013A patent/EA201890013A1/ru unknown
- 2016-06-08 US US15/735,371 patent/US11166983B2/en active Active
- 2016-06-08 CN CN202210397884.3A patent/CN114958738A/zh active Pending
- 2016-06-08 JP JP2017564369A patent/JP6799895B2/ja active Active
- 2016-06-08 EP EP19207256.9A patent/EP3623468A1/en active Pending
-
2018
- 2018-01-08 ZA ZA2018/00121A patent/ZA201800121B/en unknown
- 2018-04-23 HK HK18105236.3A patent/HK1245831A1/zh unknown
-
2021
- 2021-05-04 US US17/307,754 patent/US20210361708A1/en active Pending
- 2021-05-04 US US17/307,658 patent/US20210361707A1/en active Pending
-
2022
- 2022-07-15 AU AU2022205271A patent/AU2022205271A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3307875B1 (en) | 2021-12-15 |
AU2022205271A1 (en) | 2022-08-11 |
US20210361708A1 (en) | 2021-11-25 |
CA2988050A1 (en) | 2016-12-15 |
EP3623468A1 (en) | 2020-03-18 |
EA201890013A1 (ru) | 2018-07-31 |
CN114958738A (zh) | 2022-08-30 |
US20210361707A1 (en) | 2021-11-25 |
AU2016274633B2 (en) | 2022-04-21 |
ZA201800121B (en) | 2019-08-28 |
CN108350428B (zh) | 2022-04-22 |
JP2018516586A (ja) | 2018-06-28 |
JP6799895B2 (ja) | 2020-12-16 |
CN108350428A (zh) | 2018-07-31 |
EP3307875A1 (en) | 2018-04-18 |
WO2016198480A1 (en) | 2016-12-15 |
AU2016274633A1 (en) | 2018-02-01 |
US20180169147A1 (en) | 2018-06-21 |
US11166983B2 (en) | 2021-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245831A1 (zh) | 用於生產TCRγδ+ T細胞的方法 | |
HK1246825A1 (zh) | 細胞 | |
HK1252162A1 (zh) | 細胞 | |
HK1250667A1 (zh) | 細胞 | |
GB201506423D0 (en) | Gamma delta T cells and uses thereof | |
IL249970B (en) | Gamma delta T cells and their uses | |
GB201507368D0 (en) | Cell | |
GB201503500D0 (en) | Cell | |
HK1255101A1 (zh) | 用於得到調節性t細胞的方法及其用途 | |
EP3380655A4 (en) | MANUFACTURING SYSTEM OF LARGE SCALE CELLS | |
HK1250931A1 (zh) | 誘導有絲分裂期後細胞的細胞分裂的方法 | |
SI3365107T1 (sl) | Celična kultura | |
SG11201705095VA (en) | Process for the manufacture of solar cells | |
HK1248774A1 (zh) | 細胞測定方法 | |
SG11201700908TA (en) | Method for increasing the specific production rate of eukaryotic cells | |
PT3307875T (pt) | Métodos para a produção de células t tcr gamma delta+ | |
SG11201609269TA (en) | Method of culturing cells | |
GB201506524D0 (en) | Methods for the production of 2-D materials | |
PT3194599T (pt) | Método para produção de células modificadas que expressam hox e células modificadas obtidas pelo método | |
AU2014905202A0 (en) | Method of inducing cells | |
GB201507819D0 (en) | Cell | |
GB201507816D0 (en) | Cell | |
GB201507812D0 (en) | Cell | |
GB201507814D0 (en) | Cell | |
GB201418664D0 (en) | Methods for the production of 2-D materials |